1. Home
  2. XENE

as 09-05-2025 3:21pm EST

$
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Founded: 1996 Country:
Canada
Canada
Employees: N/A City: BURNABY
Market Cap: 2.4B IPO Year: 2014
Target Price: $52.73 AVG Volume (30 days): 834.3K
Analyst Decision: Strong Buy Number of Analysts: 11
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -3.54 EPS Growth: N/A
52 Week Low/High: $26.74 - $46.00 Next Earning Date: 08-11-2025
Revenue: $7,500,000 Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): 256.34%

XENE Daily Stock ML Predictions

Share on Social Networks: